A--to expand the scope of the program by re-introducing the manufacture and distri

lular products for use in human subjects participating in clinical trials under investigational new drug (IND) applications for the cell product.

The primary purpose of the acquisition for the Production Assistance for Cellular Therapy (PACT) III program contract awards is to expand the scope of the program by re-introducing the manufacture and distribution of cel